The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20150756: Hess North Cliff Voting, LLC; Northern Frac Proppants II, LLC
Graco Inc., Illinois Tool Works Inc., and ITW Finishing LLC, In the Matter of
The FTC challenged Graco Inc.'s proposed $650 million acquisition of ITW Finishing LLC from Illinois Tool Works Inc., alleging that it would harm competition in the market for equipment used to apply paints and other liquid finishes to a variety of manufactured goods, such as cars, wood cabinets, and major appliances. In March 2012, the FTC issued an order requiring Graco Inc. to hold separate the worldwide liquid finishing equipment businesses of Illinois Tool Works Inc. and ITW Finishing LLC, while allowing Graco to complete its proposed $650 million acquisition of all of ITW's finishing equipment businesses. The Commission also withdrew its court challenge to the deal. On 5/31/2012, the FTC required Graco Inc., a leader in the worldwide market for key industrial finishing equipment, to sell the worldwide liquid finishing business of Illinois Tool Works Inc. and ITW Finishing LLC under a proposed order, as part of a settlement resolving charges that its $650 million acquisition of several ITW businesses would have been anticompetitive and led to higher prices and reduced innovation for the North American manufacturers who rely on this equipment.
Prepared Statement Before the U.S. House of Representatives Committee on the Judiciary
Prepared Statement of Commissioner Joshua D. Wright on Wrecking the Internet to Save it? The FCC’s Net Neutrality Rule
Par Petroleum Corporation and Mid Pac Petroleum, LLC; Analysis of Proposed Consent Order to Aid Public Comment
Documents created by Ted Cruz and his personnel file during his time at the FTC
20150701: Group 1 Automotive, Inc.; Irvin David Irrevocable Trust
Sun Pharmaceutical Industries, Ltd., et al., In the Matter of
Pharmaceutical companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. agreed to divest Ranbaxy’s interests in generic minocycline tablets in order to settle FTC charges that Sun’s $4 billion proposed acquisition of Ranbaxy would likely be anticompetitive. Torrent Pharmaceuticals Ltd., a global drug company based in India that markets generic drugs in the United States, will acquire the divested assets. Under the settlement, Sun and Ranbaxy must also sell Ranbaxy’s generic minocycline capsule assets to Torrent, to enable Torrent to achieve regulatory approval for a change in ingredient suppliers for its minocycline tablets as quickly as Ranbaxy would have been able to do in the absence of the deal. In addition, Sun and Ranbaxy must supply generic minocycline tablets and capsules to Torrent until the company establishes its own manufacturing infrastructure.